Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a non-interventional observation study

BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) belong among the most burdensome side effects in hemato-oncology. Mostly, a combination of ondansetron and dexamethasone is used as antiemetic prophylaxis in pediatric patients undergoing emetogenic chemotherapy. However, dexamethasone is p...

Descripción completa

Detalles Bibliográficos
Autores principales: Willier, Semjon, Cabanillas Stanchi, Karin Melanie, von Have, Martina, Binder, Vera, Blaeschke, Franziska, Feucht, Judith, Feuchtinger, Tobias, Döring, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858739/
https://www.ncbi.nlm.nih.gov/pubmed/31730451
http://dx.doi.org/10.1186/s12885-019-6252-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858739/
https://www.ncbi.nlm.nih.gov/pubmed/31730451
http://dx.doi.org/10.1186/s12885-019-6252-6

Ejemplares similares